Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
The new program includes upstream and downstream process development and large-scale GMP production.
Subscribe To Our Newsletter & Stay Updated
